Dementia Alzheimers Clinical Trials
2 recruiting trials for Dementia Alzheimers. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Dementia Alzheimers clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Bitbrain (1), Hanze University of Applied Sciences Groningen (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Home Lab (device, 1 trial), followed by GAITRite walkway system OR 4-meter walking speed test, Jamar hand dynamometer.
Track Dementia Alzheimers trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
HOme-based Brain Monitoring With a GARment-EEG to Study Cognitive Decline in the Aging Population
This study will investigate the validity of the HOGAR EEG/PSG monitoring kit designed by Bitbrain as a tool for characterizing and assessing cognitive function in older adults, as...
Language, Speech and Motor Function in MCI Due to AD and Alzheimer's Disease
The goal of this observational cross-sectional study is to explore the characteristics of language, speech, and motor function in persons with Mild Cognitive Impairment due to...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Dementia Alzheimers, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Dementia Alzheimers, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Dementia Alzheimers, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.